W.O.M. World of Medicine AG

euro adhoc: W.O.M. World of Medicine AG
Mergers - Acquisitions - Takeovers / Management Board and Supervisory Board publish statement on mandatory offer from ATON GmbH pursuant to Section 27 of the German Securities Acquisition and Takeover Act

-------------------------------------------------------------------------------- Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. -------------------------------------------------------------------------------- C.E.O. Interviews 27.06.2007 The Management Board and Supervisory Board of W.O.M. WORLD OF MEDICINE AG published a joint statement today on the mandatory offer from ATON GmbH to the shareholders of W.O.M. WORLD OF MEDICINE AG, in compliance with German Securities Acquisition and Takeover Act (WpÜG) Section 27. In the statement, they recommend shareholders accept the mandatory offer in the amount of EUR8.00 for each bearer share certificate in WORLD OF MEDICINE (ISIN DE0006637390). Majority shareholder Peter P. Wiest, who is also CEO of WORLD OF MEDICINE, indicates in the statement that he does not intend to accept the mandatory offer for his portfolio of shares, equal to 50.58% of the voting stock in W.O.M. WORLD OF MEDICINE AG. All other Management Board and Supervisory Board Members intend to accept the offer. Management Board and Supervisory Board indicate in the statement that the offering price complies with legal mandates, and they deem the price to be equitable. The acceptance period for the offer began June 18, 2007 and will end on July 16, 2007. The full statement (only German) as well as a press release were published today at www.world-of-medicine.com/2007/compulsoryoffer/index.php. The Management Board end of announcement euro adhoc 27.06.2007 12:08:39 -------------------------------------------------------------------------------- ots Originaltext: W.O.M. World of Medicine AG Im Internet recherchierbar: http://www.presseportal.ch Further inquiry note: Stefanie Gehrke Tel.: +49 (0)30 39981 566 E-Mail: stefanie.gehrke@womcorp.com Branche: Pharmaceuticals ISIN: DE0006637390 WKN: 663739 Index: CDAX, Prime All Share, Technologie All Share Börsen: Börse Frankfurt / regulated dealing/prime standard Börse Berlin / free trade Börse Hamburg / free trade Börse Stuttgart / free trade Börse Düsseldorf / free trade Börse München / free trade

Das könnte Sie auch interessieren: